Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Meet Our Team

The Sygnature leadership team encompasses a rich mix of backgrounds, experiences and skills. Passionate scientists, chemists, biochemists, biologists, computational chemists, and pharmacologists work together to make Sygnature the partner of choice, the expert provider of drug discovery services who will do everything to make your project succeed.

Filter by:

Dr Simon Hirst

Chief Executive Officer


Dr Paul Overton

Chief Commercial Officer


Dr Jonathan Williams

Chief Operating Officer


Mrs Louisa Jordison

Chief Financial Officer


Who We Are

Sygnature Discovery prides itself on offering a unique, high-quality, distinctive and tailored integrated drug discovery service to our clients. Our mission is to be admired for the science we do,…


Working with Us

No two projects will ever be the same, but there are commonly recurring challenges that hinder progress towards a strong candidate molecule. Sygnature draws on the past experience of over…


Company History

Since 2004 Sygnature Discovery has been offering high-quality drug discovery services and providing guidance and support to customers for the discovery and development of novel medicines. We have grown significantly…


Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.